Journal
CLINICAL CHEMISTRY AND LABORATORY MEDICINE
Volume 46, Issue 1, Pages 27-42Publisher
WALTER DE GRUYTER GMBH
DOI: 10.1515/CCLM.2008.006
Keywords
blood plasma and serum; coronary heart disease; data analysis; diagnostics; lipoprotein subclass; metabolomics; metabonomics; nuclear magnetic resonance spectroscopy; quantification; risk assessment
Categories
Ask authors/readers for more resources
This review focuses on (i) the current status of H-1 NMR spectroscopy to quantify lipoprotein subclasses directly from serum or plasma, and (ii) the applications of H-1 NMR metabonomics of serum in biomedicine. Related to both themes, experimental and data analysis methodologies are discussed together with the biochemical rationales. Particular emphasis is placed on the concepts of risk assessment and diagnostics in relation to the potential clinical role of H-1 NMR metabonomics; recent applications in the area of coronary heart disease and diabetes are addressed in more detail.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available